
CRWV · Nasdaq
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Total Revenue | $5.13B | $1.92B | $229.00M |
| Cost of Revenue | $1.45B | $493.00M | $69.00M |
| Research & Development | $352.00M | $56.00M | $21.00M |
| Selling, General & Administrative | $651.00M | $119.00M | $30.00M |
| Operating Expenses | $5.18B | $1.59B | $243.00M |
| Operating Income | -$46.00M | $324.00M | -$14.00M |
| Interest Expense | $1.15B | $349.00M | $27.00M |
| Other Income / (Expense) | $33.00M | $49.00M | $18.00M |
| Income Before Taxes | -$1.22B | -$744.00M | -$558.00M |
| Provision for Income Taxes | -$48.00M | $119.00M | $36.00M |
| Net Income | -$1.17B | -$863.00M | -$594.00M |
| Basic EPS | -$2.75 | -$4.30 | -$3.09 |
| Diluted EPS | -$2.81 | -$4.30 | -$3.09 |
| Basic Shares Outstanding | 435.00M | 218.00M | 192.00M |
| Diluted Shares Outstanding | 436.00M | 218.00M | 192.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | -$5.19 | -$5.55 | -$4.06 | 9 | ↑0 ↓2 |
| Dec 2027 | -$3.47 | -$4.68 | -$1.56 | 9 | ↑0 ↓1 |
| Dec 2028 | -$2.45 | -$4.66 | $1.25 | 5 | ↑0 ↓0 |